EVIDENCE THAT ENHANCEMENT OF CHOLINERGIC TONE INCREASES BASAL PLASMA-LEVELS OF CALCITONIN-GENE-RELATED PEPTIDE IN NORMAL MAN

被引：14

作者：

TRASFORINI, G ^{[1
]}

MARGUTTI, A ^{[1
]}

VERGNANI, L ^{[1
]}

AMBROSIO, MR ^{[1
]}

VALENTINI, A ^{[1
]}

ROSSI, R ^{[1
]}

PORTALUPPI, F ^{[1
]}

UBERTI, ECD ^{[1
]}

机构：

[1] UNIV FERRARA, DEPT ENDOCRINOL, CHAIR ENDOCRINOL, I-44100 FERRARA, ITALY

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1994年 / 78卷 / 03期

关键词：

D O I：

10.1210/jc.78.3.763

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To investigate the influence of the cholinergic system on the modulation of the circulating levels of calcitonin gene-related peptide (CGRP) under basal conditions in normal man, the effects of an acetylcholinesterase inhibitor, pyridostigmine bromide, and a muscarinic receptor blocker, pirenzepine, were studied in 16 normal subjects (8 females and 8 males). Pyridostigmine (120 mg, orally) induced a significant (P < 0.01) rise in basal plasma CGRP, while it reduced systolic and diastolic blood pressure. In all subjects, pirenzepine (0.6 mg/kg, iv bolus) was unable to modify the basal CGRP level. In conclusion, a pharmacologically induced enhancement of cholinergic tone resulted in an increase in CGRP, whereas muscarinic receptor blockade had no effect on CGRP levels or blood pressure. Therefore, the cholinergic system seems to be involved in the control of CGRP release in man, acting as a positive modulator. However, the available data do not indicate that there is a tonic cholinergic tone responsible for CGRP secretion under physiological conditions.

引用

页码：763 / 766

页数：4

共 30 条

[21] CALCITONIN GENE-RELATED PEPTIDE IMMUNOREACTIVE SENSORY AND MOTOR NERVES OF THE RAT, CAT, AND MONKEY ESOPHAGUS [J].

RODRIGO, J ;

POLAK, JM ;

FERNANDEZ, L ;

GHATEI, MA ;

MULDERRY, P ;

BLOOM, SR .

GASTROENTEROLOGY, 1985, 88 (02) :444-451

[22] PRODUCTION OF A NOVEL NEUROPEPTIDE ENCODED BY THE CALCITONIN GENE VIA TISSUE-SPECIFIC RNA PROCESSING [J].

ROSENFELD, MG ;

MERMOD, JJ ;

AMARA, SG ;

SWANSON, LW ;

SAWCHENKO, PE ;

RIVIER, J ;

VALE, WW ;

EVANS, RM .

NATURE, 1983, 304 (5922) :129-135

[23]

SIREN AL, 1988, J PHARMACOL EXP THER, V247, P69

[24] HUMAN CALCITONIN GENE RELATED PEPTIDE - A POTENT ENDOGENOUS VASODILATOR IN MAN [J].

STRUTHERS, AD ;

BROWN, MJ ;

MACDONALD, DWR ;

BEACHAM, JL ;

STEVENSON, JC ;

MORRIS, HR ;

MACINTYRE, I .

CLINICAL SCIENCE, 1986, 70 (04) :389-393

[25] EFFECT OF CALCITONIN GENE-RELATED PEPTIDE ON CONTRACTION OF STRIATED-MUSCLE IN THE MOUSE [J].

TAKAMI, K ;

KAWAI, Y ;

UCHIDA, S ;

TOHYAMA, M ;

SHIOTANI, Y ;

YOSHIDA, H ;

EMSON, PC ;

GIRGIS, S ;

HILLYARD, CJ ;

MACINTYRE, I .

NEUROSCIENCE LETTERS, 1985, 60 (02) :227-230

[26] IMMUNOHISTOCHEMICAL EVIDENCE FOR THE COEXISTENCE OF CALCITONIN GENE-RELATED PEPTIDE-LIKE AND CHOLINE ACETYLTRANSFERASE-LIKE IMMUNOREACTIVITY IN NEURONS OF THE RAT HYPOGLOSSAL, FACIAL AND AMBIGUUS NUCLEI [J].

TAKAMI, K ;

KAWAI, Y ;

SHIOSAKA, S ;

LEE, Y ;

GIRGIS, S ;

HILLYARD, CJ ;

MACINTYRE, I ;

EMSON, PC ;

TOHYAMA, M .

BRAIN RESEARCH, 1985, 328 (02) :386-389

[27] CIRCADIAN PROFILE OF PLASMA CALCITONIN GENE-RELATED PEPTIDE IN HEALTHY MAN [J].

TRASFORINI, G ;

MARGUTTI, A ;

PORTALUPPI, F ;

MENEGATTI, M ;

AMBROSIO, MR ;

BAGNI, B ;

PANSINI, R ;

UBERTI, ECD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05) :945-951

[28] CALCITONIN GENE-RELATED PEPTIDE (CGRP) - PERIVASCULAR DISTRIBUTION AND VASODILATORY EFFECTS [J].

UDDMAN, R ;

EDVINSSON, L ;

EKBLAD, E ;

HAKANSON, R ;

SUNDLER, F .

REGULATORY PEPTIDES, 1986, 15 (01) :1-23

[29] THE CALCITONIN GENE PEPTIDES - BIOLOGY AND CLINICAL RELEVANCE [J].

ZAIDI, M ;

MOONGA, BS ;

BEVIS, PJR ;

BASCAL, ZA ;

BREIMER, LH .

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1990, 28 (02) :109-174

[30] CIRCULATING CGRP COMES FROM THE PERIVASCULAR NERVES [J].

ZAIDI, M ;

BEVIS, PJR ;

GIRGIS, SI ;

LYNCH, C ;

STEVENSON, JC ;

MACINTYRE, I .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 117 (02) :283-284

← 1 2 3 →